Joel Greenblatt's LFST Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 74,840 shares of LifeStance Health Group, Inc. (LFST) worth $526,874, representing 0.00% of the portfolio. First purchased in 2025-Q1, this short-term holding has been held for 4 quarters.
Based on 13F filings, Joel Greenblatt has maintained this position in LFST for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 26,587 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's LifeStance Health Group (LFST) Holding Value Over Time
Track share changes against reported price movement
Quarterly LifeStance Health Group (LFST) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +724 | Add 0.98% | 74,840 | $7.04 |
| Q3 2025 | +26,587 | Add 55.94% | 74,116 | $5.50 |
| Q2 2025 | +15,601 | Add 48.86% | 47,529 | $5.17 |
| Q1 2025 | +31,928 | New Buy | 31,928 | $6.66 |
Joel Greenblatt's LifeStance Health Group Investment FAQs
Joel Greenblatt first purchased LifeStance Health Group, Inc. (LFST) in Q1 2025, acquiring 31,928 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held LifeStance Health Group, Inc. (LFST) for 4 quarters since Q1 2025.
Joel Greenblatt's largest addition to LifeStance Health Group, Inc. (LFST) was in Q1 2025, adding 31,928 shares worth $212,640.
According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 74,840 shares of LifeStance Health Group, Inc. (LFST), valued at approximately $526,874.
As of the Q4 2025 filing, LifeStance Health Group, Inc. (LFST) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in LifeStance Health Group, Inc. (LFST) was 74,840 shares, as reported at the end of Q4 2025.